Gainers
- Autonomix Medical AMIX shares moved upwards by 11.1% to $1.3 during Tuesday's after-market session. The company's market cap stands at $24.4 million.
- Unicycive Therapeutics UNCY stock increased by 6.09% to $0.69. The company's market cap stands at $26.1 million.
- Venus Concept VERO stock increased by 5.71% to $1.11. The company's market cap stands at $7.0 million.
- Gossamer Bio GOSS stock moved upwards by 4.99% to $0.54. The market value of their outstanding shares is at $121.2 million.
- Capricor Therapeutics CAPR stock moved upwards by 4.86% to $5.82. The market value of their outstanding shares is at $185.1 million.
- Poseida Therapeutics PSTX stock moved upwards by 4.72% to $2.88. The market value of their outstanding shares is at $279.2 million.
Losers
- Calidi Biotherapeutics CLDI shares fell 15.3% to $0.23 during Tuesday's after-market session. The company's market cap stands at $14.6 million.
- BioSig Technologies BSGM stock decreased by 14.88% to $0.4. The company's market cap stands at $5.6 million.
- ThermoGenesis Holdings THMO shares decreased by 14.12% to $0.46. The market value of their outstanding shares is at $3.6 million.
- Adlai Nortye ANL stock decreased by 11.5% to $3.31. The company's market cap stands at $122.1 million.
- Avid Bioservices CDMO stock declined by 8.89% to $7.28. The company's market cap stands at $462.1 million.
- Immuneering IMRX shares decreased by 8.29% to $1.55. The company's market cap stands at $45.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ANLAdlai Nortye Ltd
$1.88-8.29%
BSGMBioSig Technologies Inc
$1.257.76%
CAPRCapricor Therapeutics Inc
$14.042.51%
CDMOAvid Bioservices Inc
$12.410.16%
CLDICalidi Biotherapeutics Inc
$0.8771-1.88%
GOSSGossamer Bio Inc
$0.9460-1.65%
IMRXImmuneering Corp
$2.083.05%
THMOThermoGenesis Holdings Inc
$0.00070-%
UNCYUnicycive Therapeutics Inc
$0.65285.29%
VEROVenus Concept Inc
$0.3351-7.61%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in